Comparative effects of oxaliplatin-based versus irinotecan-based regimens combined with capecitabine and bevacizumab in patients with colorectal cancer and liver metastases

The oxaliplatin-based regimen significantly improves tumor control, biomarker profiles, survival, and patient well-being, with fewer adverse effects, supporting its clinical applicability.

Authors

Institutions

Publication Details

Journal
American Journal of Cancer Research
Published
2025-01-01
DOI
https://doi.org/10.62347/wfpe2805
Citations
1
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative effects of oxaliplatin-based versus irinotecan-based regimens combined with capecitabine and bevacizumab in patients with colorectal cancer and liver metastases

Yayun Liang
1 citations
American Journal of Cancer Research
Colorectal Cancer Treatments and Studies
1.05
article

Comparative effects of oxaliplatin-based versus irinotecan-based regimens combined with capecitabine and bevacizumab in patients with colorectal cancer and liver metastases

Yayun Liang
article en
1 citations

Abstract

The oxaliplatin-based regimen significantly improves tumor control, biomarker profiles, survival, and patient well-being, with fewer adverse effects, supporting its clinical applicability.

American Journal of Cancer ResearchVol. 15(10)
Shanxi Provincial Cancer Hospital (CN)
Openalex Percentile: Top 16%
Colorectal Cancer Treatments and Studies
1.05
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparative effects of oxaliplatin-based versus irinotecan-based regimens combined with capecitabine and bevacizumab in patients with colorectal cancer and liver metastases — Yayun Liang · American Journal of Cancer Research (2025) | TGRS Research Map | TGRS